PM01183 . Oncologos del Hospital General de Massachusetts ( Boston // EEUU ) Presentaran datos de la Fase II Sarcoma en el Congreso CTOS que se esta celebrando en Portugal del 9 al 12 de Noviembre .

*.-  A phase II multi-strata study of PM1183 as a single agent or in combination with conventional chemotherapy in metastatic and/or unresectable soft tissue sarcoma .

 (abstract #2558960 / Poster 097) .

Poster session 2 – Soft Tissue Sarcomas. Friday, 11th of November 10:40 am – 7:00 pm and Saturday 12th of November 7:00 am – 4:00 pm. Foyer room.


Lead author: Gregory M. Cote, et al. Hematology/Oncology, Massachusetts General Hospital, Boston, MA, USA.

*************************************

A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable Sarcomas

This study is ongoing, but not recruiting participants.

Sponsor:

Massachusetts General Hospital

Collaborators:

Dana-Farber Cancer Institute

PharmaMar

Information provided by (Responsible Party):

Gregory Cote, Massachusetts General Hospital

ClinicalTrials.gov Identifier:

NCT02448537

First received: May 15, 2015

Last updated: October 5, 2016

Last verified: October 2016